DOCSLIB.ORG

Ribosome Protection by Antibiotic Resistance ATP-Binding Cassette Protein

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ribosome Protection by Antibiotic Resistance ATP-Binding Cassette Protein Ribosome protection by antibiotic resistance ATP-binding cassette protein Weixin Sua,b,1, Veerendra Kumarc,1, Yichen Dingd,1, Rya Eroa,b,2, Aida Serraa, Benjamin Sian Teck Leea, Andrew See Weng Wongb, Jian Shie, Siu Kwan Szea, Liang Yanga,d,2, and Yong-Gui Gaoa,b,c,2 aSchool of Biological Sciences, Nanyang Technological University, Singapore 637551; bInstitute of Structural Biology, Nanyang Technological University, Singapore 639798; cInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore 138673; dSingapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore 637551; and eCentre for BioImaging Sciences, National University of Singapore, Singapore 117557 Edited by Peter B. Moore, Yale University, New Haven, CT, and approved April 11, 2018 (received for review February 23, 2018) The ribosome is one of the richest targets for antibiotics. Unfortu- peptide bond formation that underlies translation arrest (10, 11). nately, antibiotic resistance is an urgent issue in clinical practice. However, certain oligopeptides are believed to lead to drug re- Several ATP-binding cassette family proteins confer resistance to sistance by “flushing out” the macrolides while passing through ribosome-targeting antibiotics through a yet unknown mechanism. the NPET (13, 14). Therefore, the fate of the macrolide-bound Among them, MsrE has been implicated in macrolide resistance. Here, ribosome is determined by the dynamic interactions among the we report the cryo-EM structure of ATP form MsrE bound to the bound drug, the PTC, and the sequence specificity of the emerging ribosome. Unlike previously characterized ribosomal protection pro- oligopeptide chain (5, 15). It should be noted, however, that teins,MsrEisshowntobindtoribosomal exit site. Our structure macrolides could induce ribosomal arrest by allosterically altering reveals that the domain linker forms a unique needle-like arrangement the PTC even without forming significant contacts with the nascent with two crossed helices connected by an extended loop projecting chain, demonstrating the existence of a functional link between the into the peptidyl-transferase center and the nascent peptide exit NPET and the PTC (16). tunnel, where numerous antibiotics bind. In combination with bio- A wide range of mechanisms mediate antibiotic resistance, one chemical assays, our structure provides insight into how MsrE binding of the greatest threats to public health and food security world- leads to conformational changes, which results in the release of the wide. In the case of macrolides, various bacterial species are in- drug. This mechanism appears to be universal for the ABC-F type trinsically insensitive due to chromosomal mutations in ribosomal ribosome protection proteins. genes causing reduced drug-binding efficiency (17, 18). The most common acquired resistance mechanism is the posttranscriptional ribosome protection | antibiotic resistance | ABC-F | MsrE | methylation of the 23S rRNA by methyltransferases (e.g., Erm protein synthesis family), which also results in decreased drug-binding efficiency (1, ore than one-half of the antibiotics in clinical use target Significance Mbacterial ribosome and protein synthesis, particularly the elongation step (1). The peptidyl-transferase center (PTC) and ARE ABC-F genes have been found in numerous pathogen genomes the adjacent nascent peptide exit tunnel (NPET) in the ribosomal and multi-drug resistance conferring plasmids. Further transmission large subunit are the key players in protein elongation, with func- will challenge the clinical use of many antibiotics. The development tions in catalyzing the peptide bond formation and the emergence of of improved ribosome-targeting therapeutics relies on the elucida- the nascent chain, respectively. PTC-targeting antibiotics, such as tion of the resistance mechanisms. Characterization of MsrE protein chloramphenicol, group A streptogramins, lincosamides, and pleu- bound to the bacterial ribosome is first of its kind for ARE ABC-F members. Together with biochemical data, it sheds light on the ri- romutilins, inhibit protein synthesis by interfering with the correct BIOCHEMISTRY positioning of the tRNA substrates (1, 2). In contrast, macrolides bosome protection mechanism by domain linker-mediated confor- and group B streptogramins bind to a site within the NPET adjacent mational change and displacement leading to drug release, to the PTC and immediately before the constriction point at which suggesting a mechanism shared by other ARE ABC-F proteins. These ribosomal proteins (r-proteins) L4 and L22 narrow the tunnel width proteins present an intriguing example of structure-function re- to approximately 10 Å (3, 4). lationship and a medically relevant target of study as they collec- The primary mechanism of macrolide action is believed to be the tively mediate resistance to the majority of antibiotic classes context-specific inhibition of peptide bond formation rather than targeting the peptidyl-transferase center region. the indiscriminate obstruction of nascent chain passage through the NPET. Namely, ribosome-profiling analyses have revealed that Author contributions: L.Y. and Y.-G.G. initiated the project; Y.-G.G. directed the project; W.S., V.K., Y.D., R.E., A.S., B.S.T.L., and S.K.S. performed the experiments; W.S., V.K., R.E., translation of most genes proceeds past the first six to eight codons and Y.-G.G. analyzed the data, determined the structure, and built the model; A.S.W.W. and can be arrested at any point during the translation when the and J.S. helped with data collection; and W.S., V.K., R.E., and Y.-G.G. wrote the manu- ribosome encounters specific short-sequence motifs (5–7). The script with input from all members. problematic sequence motifs are confined to the nascent peptide The authors declare no conflict of interest. residues in the PTC, not the peptide segment in contact with the This article is a PNAS Direct Submission. macrolide further down the NPET (5). Therefore, it appears that This open access article is distributed under Creative Commons Attribution-NonCommercial- the general mode of macrolide action involves selective inhibition NoDerivatives License 4.0 (CC BY-NC-ND). of peptide bond formation between specific combinations of donor Data deposition: The atomic coordinates and cryo-EM map have been deposited in the and acceptor substrates. In some cases, the macrolide-induced and Protein Data Bank, www.wwpdb.org (PDB ID code 5ZLU) and Electron Microscopy Data leader peptide-mediated translational arrest is used to regulate the Bank (accession no. EMD-6934), respectively. expression of downstream macrolideresistancemethyltransferase 1W.S., V.K., and Y.D. contributed equally to this work. genes, such as ermB and ermC (8–12). 2To whom correspondence may be addressed. Email: [email protected], yangliang@ntu. Structural characterization of the erythromycin-ErmBL leader edu.sg, or [email protected]. peptide-ribosome complex reveals that the drug redirects the This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. path of the peptide in the tunnel and leads to conformational 1073/pnas.1803313115/-/DCSupplemental. changes in PTC and tRNA substrates unable to participate in the Published online April 30, 2018. www.pnas.org/cgi/doi/10.1073/pnas.1803313115 PNAS | May 15, 2018 | vol. 115 | no. 20 | 5157–5162 Downloaded by guest on September 24, 2021 19). Ribosome protection mechanism, by which the drug is actively removed from the ribosome, has recently become of great interest. The ATP-binding cassette F (ABC-F) family proteins confer resistance to a number of clinically relevant antibiotics targeting the ribosome PTC/NPET region (20). These proteins are collectively referred to as antibiotic resistance (ARE) ABC-F proteins (21). Unlike other ARE ABC family members that are shown to actively pump drugs out of the cells, ARE ABC-F proteins lack the trans- membrane domain characteristic to transporters and are believed to confer antibiotic resistance via ribosomal protection mechanism by interacting with the ribosome and displacing the bound drug (17, 20, 22–24). ARE ABC-F proteins have been classified into three groups based on antibiotic resistance: (i) Msr homologs (macrolides and streptogramin B), (ii) Vga/Lsa/Sal homologs (lincosamides, pleuromutilins, and streptogramin A), and (iii) OptrA homologs (phenicols and oxazolidinones) (20) (SI Appendix,Fig.S1). Notably, these proteins compose two ATP-binding domains connected by a linker of various lengths, which appears to be crucial for the effi- ciency and specificity of antibiotic resistance (20). However, an understanding of the molecular mechanism of how ARE ABC-F proteins interact with ribosomes to mediate antibiotic resistance requires a high-resolution structure of the complex. Here we report the cryo-EM structure of the ARE ABC-F protein MsrE bound to the bacterial ribosome at 3.6-Å resolution. Note that the Msr homologs (divided into four classes: A, C, D, and E) have the longest domain linkers among the ARE ABC-F members (SI Appendix,Fig.S1). Furthermore, we have previously identified a Pseudomonas aeruginosa clinical isolate carrying the msrE gene obtained through horizontal gene transfer (NCBI ac- Fig. 1. Cryo-EM structure of the MsrE-ribosome complex. (A) Electron density cession ID: CP020704), which highlights the importance of the of the overall complex. Ribosome 50S and 30S subunits are shown in pale ARE ABC-F
Load more

Recommended publications
  • Survey of Tiamulin+Oxytetracyclinein Control of CRD Complex Due to La Sota Vaccine in Broiler Chickens
    Available online a t www.scholarsresearchlibrary.com Scholars Research Library European Journal of Zoological Research, 2013, 2 (4): 45-49 (http://scholarsresearchlibrary.com/archive.html) ISSN: 2278–7356 Survey of Tiamulin+Oxytetracyclinein control of CRD complex due to La Sota vaccine in broiler chickens Adel Feizi Department of Clinical Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran _____________________________________________________________________________________________ ABSTRACT Mycoplasma gallisepticum (MG) is one of the most important diseases of poultry industry in Iran and all over the world. Mortality, poor weight gain and increasing of feed conversion ratio (FCR) were seen in MG infected flocks. Several drugs are used for prevention and control of MG, the purpose of this study was to investigateoxytetracycline + Tiamulinefficacy on MG, and its role on broilers performance.In this study, 240 Ross 308 broilers divided in 2 groups. In one of the groups, oxytetracycline + Tiamulinwere used in days 21 to 30 following La Sota vaccination for controlling vaccination reaction and in the secondgroup, placebo was used and that group mentioned as a control group. Gross lesions, mortality, and growth parameters include body weight gain,feed intake and FCR were calculated in all groups weekly after 21 st day.Results showed that in treatment groups mortality percent was significantly (p<0.05) lower than control group and pericarditis, perihepatitis and airsacculitis was sever in control groups in comparison to antibiotic treated groups. Also body weight and FCR was significantly were different between control group and oxytetracycline + Tiamulin group (p<0.05).It can be concluded that usage of these antibiotics simultaneously could prevent vaccination reaction due to La Sota vaccine and also following MG complications, economical losses in poultry and finally it can be improve broilers performance Key words: Vaccination Reaction, Mycoplasma Gallisepticum, Oxytetracycline, Tiamulin, Ross 308.
    [Show full text]
  • Evolution of Translation EF-Tu: Trna
    University of Illinois at Urbana-Champaign Luthey-Schulten Group NIH Resource for Macromolecular Modeling and Bioinformatics Computational Biophysics Workshop Evolution of Translation EF-Tu: tRNA VMD Developer: John Stone MultiSeq Developers Tutorial Authors Elijah Roberts Ke Chen John Eargle John Eargle Dan Wright Zhaleh Ghaemi Jonathan Lai Zan Luthey-Schulten August 2014 A current version of this tutorial is available at http://www.scs.illinois.edu/~schulten/tutorials/ef-tu CONTENTS 2 Contents 1 Introduction 3 1.1 The Elongation Factor Tu . 3 1.2 Getting Started . 4 1.2.1 Requirements . 4 1.2.2 Copying the tutorial files . 4 1.2.3 Working directory . 4 1.2.4 Preferences . 4 1.3 Configuring BLAST for MultiSeq . 5 2 Comparative Analysis of EF-Tu 5 2.1 Finding archaeal EF1A sequences . 6 2.2 Aligning archaeal sequences and removing redundancy . 8 2.3 Finding bacteria EF-Tu sequences . 11 2.4 Performing ClustalW Multiple Sequence and Profile-Profile Align- ments . 12 2.5 Creating Multiple Sequence with MAFFT . 16 2.6 Conservation of EF-Tu among the Bacteria . 16 2.7 Finding conserved residues across the bacterial and archaeal do- mains . 20 2.8 EF-Tu Interface with the Ribosome . 21 3 Computing a Maximum Likelihood Phylogenetic Tree with RAxML 23 3.1 Load the Phylogenetic Tree into MultiSeq . 25 3.2 Reroot and Manipulate the Phylogenetic Tree . 25 4 MultiSeq TCL Scripting: Genomic Context 27 5 Appendix A 30 5.1 Building a BLAST Database . 30 6 Appendix B 31 6.1 Saving QR subset of alignments in PHYLIP and FASTA format 31 6.2 Calculating Maximum Likelihood Trees with RAxML .
    [Show full text]
  • Amino Acid Specificity in Translation
    Opinion TRENDS in Biochemical Sciences Vol.30 No.12 December 2005 Amino acid specificity in translation Taraka Dale and Olke C. Uhlenbeck Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, IL 60208, USA Recent structural and biochemical experiments indicate For example, in the course of deducing the recognition that bacterial elongation factor Tu and the ribosomal rules of aaRSs, several amber-suppressor tRNA bodies A-site show specificity for both the amino acid and the were deliberately mutated such that they were amino- tRNA portions of their aminoacyl-tRNA (aa-tRNA) acylated by a different aaRS, and the resulting ‘identity- substrates. These data are inconsistent with the swapped’ tRNAs were shown to insert the new amino acid traditional view that tRNAs are generic adaptors in into protein [7,8]. In addition, suppressor tRNAs esterified translation. We hypothesize that each tRNA sequence with O30 different unnatural amino acids have been has co-evolved with its cognate amino acid, such that all successfully incorporated into protein [9]. Together, these aa-tRNAs are translated uniformly. data suggest that the translational apparatus lacks specificity for different amino acids, once they are Introduction esterified onto tRNA. The mechanism of protein synthesis is traditionally In a few isolated cases, however, the translation considered to have two phases with different specificities machinery seems to show specificity for the esterified towards the 20 amino acid side chains (Figure 1). In the amino acid. A prominent example occurs in the transami- first phase, each amino acid is specifically recognized by dation pathway, which is used as an alternative to GlnRS its cognate aminoacyl-tRNA synthetase (aaRS) and to produce Gln-tRNAGln in many bacteria and archaea esterified to the appropriate tRNA to form an aminoacyl- [10,11].
    [Show full text]
  • Antibiotic and Antibiotic Resistance
    ANTIBIOTIC AND ANTIBIOTIC RESISTANCE Helle Ericsson Unnerstad Veterinarian, Associate Professor Department of Animal Health and Antimicrobial Strategies National Veterinary Institute, Uppsala, Sweden ITP, SVA, 28 September, 2018 Antibiotics or antimicrobials? • Old definition: Antibiotics are naturally produced by microorganisms. • Perhaps more useful definitions today: Antimicrobials are compounds with direct action on microorganisms. They are used for treatment or prevention of infections. Antimicrobials are inclusive of anti-bacterials, anti-virals, anti-fungals and anti-protozoals. Antibiotics are synonymous with anti-bacterials. • “Antibiotic resistance” more familiar for the public than “antimicrobial resistance” according to WHO survey. • In many contexts antibiotic resistance and antimicrobial resistance are used synonymously. Antibiotics – toxins for bacteria Antibiotic Antibiotic activity • Bactericidal activity – kill bacteria • Bacteriostatic activity – inhibit or delay bacterial growth Mechanisms of action for antibiotics Inhibition of Inhibition of cell wall synthesis protein synthesis • Aminoglycosides • Beta lactams • Tetracyclines • Cephalosporins • Macrolides • Glycopeptides • Lincosamides • Chloramphenicol • Fusidic acid • Pleuromutilins Inhibition of Inhibition of folic acid synthesis DNA/RNA synthesis • Sulphonamides • Quinolones • Trimethoprim • Coumarins • Rifamycins Spectra of activity • Broad-spectrum antibiotics Ex. tetracyclines, fluoroquinolones, 3:d and 4:th gen cephalosporins, carbapenems (G+, G-, aerobes,
    [Show full text]
  • A Diverse Intrinsic Antibiotic Resistome from a Cave Bacterium
    ARTICLE Received 5 Jul 2016 | Accepted 1 Nov 2016 | Published 8 Dec 2016 DOI: 10.1038/ncomms13803 OPEN A diverse intrinsic antibiotic resistome from a cave bacterium Andrew C. Pawlowski1, Wenliang Wang1, Kalinka Koteva1, Hazel A. Barton2, Andrew G. McArthur1 & Gerard D. Wright1 Antibiotic resistance is ancient and widespread in environmental bacteria. These are there- fore reservoirs of resistance elements and reflective of the natural history of antibiotics and resistance. In a previous study, we discovered that multi-drug resistance is common in bacteria isolated from Lechuguilla Cave, an underground ecosystem that has been isolated from the surface for over 4 Myr. Here we use whole-genome sequencing, functional genomics and biochemical assays to reveal the intrinsic resistome of Paenibacillus sp. LC231, a cave bacterial isolate that is resistant to most clinically used antibiotics. We systematically link resistance phenotype to genotype and in doing so, identify 18 chromosomal resistance elements, including five determinants without characterized homologues and three mechanisms not previously shown to be involved in antibiotic resistance. A resistome comparison across related surface Paenibacillus affirms the conservation of resistance over millions of years and establishes the longevity of these genes in this genus. 1 Michael G. DeGroote Institute for Infectious Disease Research and the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8S 4K1. 2 Department of Biology, University of Akron, Akron, Ohio 44325, USA. Correspondence and requests for materials should be addressed to G.D.W. (email: [email protected]). NATURE COMMUNICATIONS | 7:13803 | DOI: 10.1038/ncomms13803 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13803 nderstanding the evolution and origins of antibiotic rhizophila (formerly identified as Micrococcus luteus) resistance genes is vital to predicting, preventing and (Supplementary Tables 1 and 2).
    [Show full text]
  • EF-Tu and Rnase E Are Functionally Connected
    Till min familj List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I Hammarlöf, D.L., Hughes, D. (2008) Mutants of the RNA- processing enzyme RNase E reverse the extreme slow-growth phenotype caused by a mutant translation factor EF-Tu. Molecular Microbiology, 70(5), 1194-1209 II †Bergman, J., †Hammarlöf, D.L., Hughes D. (2011) Reducing ppGpp levels rescues the extreme growth defect of mutant EF-Tu. Manuscript III Hammarlöf, D.L., Liljas, L., Hughes, D. (2011) Temperature- sensitive mutants of RNase E in Salmonella enterica. Journal of Bacteriology. In press IV †Hammarlöf, D.L., †Bergman, J., Hughes, D. (2011) Extragenic suppressors of RNase E. Manuscript †These authors contributed equally. Reprints were made with permission from the respective publishers. Contents Introduction ................................................................................................... 11 Bacterial growth ....................................................................................... 11 Translation in bacteria .............................................................................. 12 The ribosome ....................................................................................... 12 The translation cycle ............................................................................ 13 Elongation Factor Tu ................................................................................ 14 The most abundant protein in the cell .................................................
    [Show full text]
  • Crystal Structure of the Eukaryotic 60S Ribosomal Subunit in Complex with Initiation Factor 6
    Research Collection Doctoral Thesis Crystal structure of the eukaryotic 60S ribosomal subunit in complex with initiation factor 6 Author(s): Voigts-Hoffmann, Felix Publication Date: 2012 Permanent Link: https://doi.org/10.3929/ethz-a-007303759 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library ETH Zurich Dissertation No. 20189 Crystal Structure of the Eukaryotic 60S Ribosomal Subunit in Complex with Initiation Factor 6 A dissertation submitted to ETH ZÜRICH for the degree of Doctor of Sciences (Dr. sc. ETH Zurich) presented by Felix Voigts-Hoffmann MSc Molecular Biotechnology, Universität Heidelberg born April 11, 1981 citizen of Göttingen, Germany accepted on recommendation of Prof. Dr. Nenad Ban (Examiner) Prof. Dr. Raimund Dutzler (Co-examiner) Prof. Dr. Rudolf Glockshuber (Co-examiner) 2012 blank page ii Summary Ribosomes are large complexes of several ribosomal RNAs and dozens of proteins, which catalyze the synthesis of proteins according to the sequence encoded in messenger RNA. Over the last decade, prokaryotic ribosome structures have provided the basis for a mechanistic understanding of protein synthesis. While the core functional centers are conserved in all kingdoms, eukaryotic ribosomes are much larger than archaeal or bacterial ribosomes. Eukaryotic ribosomal rRNA and proteins contain extensions or insertions to the prokaryotic core, and many eukaryotic proteins do not have prokaryotic counterparts. Furthermore, translation regulation and ribosome biogenesis is much more complex in eukaryotes, and defects in components of the translation machinery are associated with human diseases and cancer.
    [Show full text]
  • Archaeal Translation Initiation Revisited: the Initiation Factor 2 and Eukaryotic Initiation Factor 2B ␣-␤-␦ Subunit Families
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 3726–3730, March 1998 Evolution Archaeal translation initiation revisited: The initiation factor 2 and eukaryotic initiation factor 2B a-b-d subunit families NIKOS C. KYRPIDES* AND CARL R. WOESE Department of Microbiology, University of Illinois at Urbana-Champaign, B103 Chemical and Life Sciences, MC 110, 407 S. Goodwin, Urbana, IL 61801 Contributed by Carl R. Woese, December 31, 1997 ABSTRACT As the amount of available sequence data bacterial and eukaryotic translation initiation mechanisms, increases, it becomes apparent that our understanding of although mechanistically generally similar, were molecularly translation initiation is far from comprehensive and that unrelated and so had evolved independently. The Methano- prior conclusions concerning the origin of the process are coccus jannaschii genome (7–9), which gave us our first wrong. Contrary to earlier conclusions, key elements of trans- comprehensive look at the componentry of archaeal transla- lation initiation originated at the Universal Ancestor stage, for tion initiation, revealed that archaeal translation initiation homologous counterparts exist in all three primary taxa. showed considerable homology with eukaryotic initiation, Herein, we explore the evolutionary relationships among the which, if anything, reinforced the divide between bacterial components of bacterial initiation factor 2 (IF-2) and eukary- initiation and that seen in the other domains. We recently have otic IF-2 (eIF-2)/eIF-2B, i.e., the initiation factors involved in shown, however, that bacterial translation initiation factor 1 introducing the initiator tRNA into the translation mecha- (IF-1), contrary to previously accepted opinion, is related in nism and performing the first step in the peptide chain sequence to its eukaryotic/archaeal (functional) counterpart, elongation cycle.
    [Show full text]
  • Effects of Oxidative Stress on Protein Translation
    International Journal of Molecular Sciences Review Effects of Oxidative Stress on Protein Translation: Implications for Cardiovascular Diseases Arnab Ghosh * and Natalia Shcherbik * Department for Cell Biology and Neuroscience, School of Osteopathic Medicine, Rowan University, 2 Medical Center Drive, Stratford, NJ 08084, USA * Correspondence: [email protected] (A.G.); [email protected] (N.S.); Tel.: +1-856-566-6907 (A.G.); +1-856-566-6914 (N.S.) Received: 24 March 2020; Accepted: 9 April 2020; Published: 11 April 2020 Abstract: Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels. Due to their multifactorial nature and wide variation, CVDs are the leading cause of death worldwide. Understanding the molecular alterations leading to the development of heart and vessel pathologies is crucial for successfully treating and preventing CVDs. One of the causative factors of CVD etiology and progression is acute oxidative stress, a toxic condition characterized by elevated intracellular levels of reactive oxygen species (ROS). Left unabated, ROS can damage virtually any cellular component and affect essential biological processes, including protein synthesis. Defective or insufficient protein translation results in production of faulty protein products and disturbances of protein homeostasis, thus promoting pathologies. The relationships between translational dysregulation, ROS, and cardiovascular disorders will be examined in this review. Keywords: protein translation; ribosome; RNA; IRES; uORF; miRNA; cardiovascular diseases; reactive oxygen species; oxidative stress; antioxidants 1. Introduction The process of protein synthesis, or protein translation, constitutes the last and final step of the central dogma of molecular biology: assembly of polypeptides based on the information encoded by mRNAs. This complex process employs multiple essential players, including ribosomes, mRNAs, tRNAs, and numerous translational factors, enzymes, and regulatory proteins.
    [Show full text]
  • Initiation Factor Eif5b Catalyzes Second GTP-Dependent Step in Eukaryotic Translation Initiation
    Initiation factor eIF5B catalyzes second GTP-dependent step in eukaryotic translation initiation Joon H. Lee*†, Tatyana V. Pestova†‡§, Byung-Sik Shin*, Chune Cao*, Sang K. Choi*, and Thomas E. Dever*¶ *Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2716; ‡Department of Microbiology and Immunology, State University of New York Health Science Center, Brooklyn, NY 11203; and §A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia Edited by Harry F. Noller, University of California, Santa Cruz, CA, and approved October 31, 2002 (received for review September 19, 2002) Initiation factors IF2 in bacteria and eIF2 in eukaryotes are GTPases In addition, when nonhydrolyzable GDPNP was substituted Met that bind Met-tRNAi to the small ribosomal subunit. eIF5B, the for GTP, eIF5B catalyzed subunit joining; however, the factor eukaryotic ortholog of IF2, is a GTPase that promotes ribosomal was unable to dissociate from the 80S ribosome after subunit subunit joining. Here we show that eIF5B GTPase activity is re- joining (7). quired for protein synthesis. Mutation of the conserved Asp-759 in To dissect the function of the eIF5B G domain and test the human eIF5B GTP-binding domain to Asn converts eIF5B to an model that two GTP molecules are required in translation XTPase and introduces an XTP requirement for subunit joining and initiation, we mutated conserved residues in the eIF5B G translation initiation. Thus, in contrast to bacteria where the single domain and tested the function of the mutant proteins in GTPase IF2 is sufficient to catalyze translation initiation, eukaryotic translation initiation.
    [Show full text]
  • Ef-G:Trna Dynamics During the Elongation Cycle of Protein Synthesis
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2015 Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis Rong Shen University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biochemistry Commons Recommended Citation Shen, Rong, "Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis" (2015). Publicly Accessible Penn Dissertations. 1131. https://repository.upenn.edu/edissertations/1131 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1131 For more information, please contact [email protected]. Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis Abstract During polypeptide elongation cycle, prokaryotic elongation factor G (EF-G) catalyzes the coupled translocations on the ribosome of mRNA and A- and P-site bound tRNAs. Continued progress has been achieved in understanding this key process, including results of structural, ensemble kinetic and single- molecule studies. However, most of work has been focused on the pre-equilibrium states of this fast process, leaving the real time dynamics, especially how EF-G interacts with the A-site tRNA in the pretranslocation complex, not fully elucidated. In this thesis, the kinetics of EF-G catalyzed translocation is investigated by both ensemble and single molecule fluorescence resonance energy transfer studies to further explore the underlying mechanism. In the ensemble work, EF-G mutants were designed and expressed successfully. The labeled EF-G mutants show good translocation activity in two different assays. In the smFRET work, by attachment of a fluorescent probe at position 693 on EF-G permits monitoring of FRET efficiencies to sites in both ribosomal protein L11 and A-site tRNA.
    [Show full text]
  • The Ribosomal Peptidyl Transferase Center: Structure, Function, Evolution, Inhibition
    Critical Reviews in Biochemistry and Molecular Biology, 40:285–311, 2005 Copyright c Taylor & Francis Inc. ! ISSN: 1040-9238 print / 1549-7798 online DOI: 10.1080/10409230500326334 The Ribosomal Peptidyl Transferase Center: Structure, Function, Evolution, Inhibition Norbert Polacek Innsbruck Biocenter, Division of ABSTRACT The ribosomal peptidyl transferase center (PTC) resides in the Genomics and RNomics, large ribosomal subunit and catalyzes the two principal chemical reactions of Innsbruck Medical University, protein synthesis: peptide bond formation and peptide release. The catalytic Innsbruck, Austria mechanisms employed and their inhibition by antibiotics have been in the Alexander S. Mankin focus of molecular and structural biologists for decades. With the elucidation Center for Pharmaceutical of atomic structures of the large ribosomal subunit at the dawn of the new Biotechnology, University of millennium, these questions gained a new level of molecular significance. The Illinois at Chicago, Chicago, crystallographic structures compellingly confirmed that peptidyl transferase is IL 60607, USA an RNA enzyme. This places the ribosome on the list of naturally occurring riboyzmes that outlived the transition from the pre-biotic RNA World to con- temporary biology. Biochemical, genetic and structural evidence highlight the role of the ribosome as an entropic catalyst that accelerates peptide bond for- mation primarily by substrate positioning. At the same time, peptide release should more strongly depend on chemical catalysis likely involving an rRNA group of the PTC. The PTC is characterized by the most pronounced accu- mulation of universally conserved rRNA nucleotides in the entire ribosome. Thus, it came as a surprise that recent findings revealed an unexpected high level of variation in the mode of antibiotic binding to the PTC of ribosomes from different organisms.
    [Show full text]